Investing
734 Articles
In a new report, RBC has a list of stocks with some of the largest percentage drops and the lowest…
Gilead Sciences may have been largely responsible for the drop in biotech stocks after politicians went after its drug costs,…
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back…
The recent violent sell-off has unnerved investors and given the bears the floor for the first time in a while.…
In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016…
ThinkstockWhen the biotech sell-off started in late February, the stocks had been market leaders for almost four years. The staggering…
Most investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position against…
In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…
courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…
After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early…
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…
Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late…
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…
After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical…
Our top personal finance-related articles today. Your wallet will thank you later.